Conditions: Metastatic Colorectal Cancer (mCRC)
Interventions: Drug: Initiation of trifluridine-tipiracil plus bevacizumab; Drug: Initiation of trifluridine-tipiracil alone
Sponsors: Brigham and Women’s Hospital; Food and Drug Administration (FDA)
Active, not recruiting Conditions: Metastatic Colorectal Cancer (mCRC)
Interventions: Drug: Initiation of trifluridine-tipiracil plus bevacizumab; Drug: Initiation of trifluridine-tipiracil alone
Sponsors: Brigham and Women’s Hospital; Food and Drug Administration (FDA)
Active, not recruiting